hydroxychloroquine and Pleuropericarditis
hydroxychloroquine has been researched along with Pleuropericarditis in 6 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Pleuropericarditis: Inflammation of both the PERICARDIUM and the PLEURA.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Glucocorticoid (GC)-dependent, colchicine-resistant idiopathic recurrent pericarditis (IRP) remains a clinical challenge." | 7.96 | Hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis: A pilot observational prospective study. ( Antonatou, K; Antonopoulos, AS; Hadziyannis, E; Lazaros, G; Lazarou, E; Leontsinis, I; Ritis, K; Simantiris, S; Skendros, P; Tousoulis, D; Vassilopoulos, D; Vlachopoulos, C, 2020) |
"Glucocorticoid (GC)-dependent, colchicine-resistant idiopathic recurrent pericarditis (IRP) remains a clinical challenge." | 3.96 | Hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis: A pilot observational prospective study. ( Antonatou, K; Antonopoulos, AS; Hadziyannis, E; Lazaros, G; Lazarou, E; Leontsinis, I; Ritis, K; Simantiris, S; Skendros, P; Tousoulis, D; Vassilopoulos, D; Vlachopoulos, C, 2020) |
Research
Studies (6)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Lazaros, G | 1 |
Antonopoulos, AS | 1 |
Antonatou, K | 1 |
Skendros, P | 1 |
Ritis, K | 1 |
Hadziyannis, E | 1 |
Lazarou, E | 1 |
Leontsinis, I | 1 |
Simantiris, S | 1 |
Vlachopoulos, C | 1 |
Tousoulis, D | 1 |
Vassilopoulos, D | 1 |
Jacquet-Lagrèze, M | 1 |
Riad, Z | 1 |
Hugon-Vallet, E | 1 |
Ferraris, A | 1 |
Fellahi, JL | 1 |
Fanouriakis, A | 1 |
Tziolos, N | 1 |
Bertsias, G | 1 |
Boumpas, DT | 1 |
Donado, CD | 1 |
Díez, EM | 1 |
Sunkureddi, PR | 1 |
Gonzalez, EB | 1 |
Washington, R | 1 |
Salazar, A | 1 |
Douglass, P | 1 |
Kwon, CM | 1 |
Jung, YW | 1 |
Yun, DY | 1 |
Kim, HD | 1 |
Cho, HS | 1 |
Hong, YH | 1 |
Choi, JH | 1 |
Lee, CK | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Optimization of Glucocorticoid Taper Strategies for Maintenance Therapy of Systemic Lupus Erythematosus Associated Immune Thrombocytopenia (SLE-ITP)[NCT05506033] | 120 participants (Anticipated) | Interventional | 2022-08-15 | Enrolling by invitation | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Reviews
2 reviews available for hydroxychloroquine and Pleuropericarditis
Article | Year |
---|---|
Left ventricular dysfunction in COVID-19: A diagnostic issue.
Topics: Azithromycin; Betacoronavirus; Biomarkers; Coronavirus Infections; COVID-19; Cytokine Release Syndro | 2020 |
Update οn the diagnosis and management of systemic lupus erythematosus.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Humanized; Autoantibodies; Azathioprine; Calc | 2021 |
Other Studies
4 other studies available for hydroxychloroquine and Pleuropericarditis
Article | Year |
---|---|
Hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis: A pilot observational prospective study.
Topics: Colchicine; Glucocorticoids; Humans; Hydroxychloroquine; Pericarditis; Prospective Studies; Recurren | 2020 |
Successful desensitization for hydroxychloroquine anaphylaxis.
Topics: Anaphylaxis; Antirheumatic Agents; Desensitization, Immunologic; Humans; Hydroxychloroquine; Lupus E | 2010 |
A 39-year-old man with sudden onset of chest pain.
Topics: Acute Disease; Adult; Antirheumatic Agents; Chest Pain; Diagnosis, Differential; Drug Therapy, Combi | 2005 |
A case of acute pericarditis with hemophagocytic syndrome, cytomegalovirus infection and systemic lupus erythematosus.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Cytomegalovirus Infections; Gastrointestinal Hemorrh | 2008 |